REPATHA
Google image searchProduct monograph
Active ingredient
evolocumab, 120 MG/ML
DIN: 02459779
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: AUTOMATED MINI-DOSER WITH PREFILLED CARTRIDGE
Schedule: Prescription / Schedule D
Company: AMGEN CANADA INC
Date: 04-APR-2017
ATC:
- C10 — LIPID MODIFYING AGENTS (ATC, ATC/DDD, )
- C10A — LIPID MODIFYING AGENTS, PLAIN (ATC, ATC/DDD)
- C10AX — Other lipid modifying agents (ATC, ATC/DDD)
- C10AX13 — EVOLOCUMAB (ATC/DDD)
Reference brand drug: Repatha
